Aberrant expression of HDACs has been reported in various cancer types11, and HDAC inhibitors (HDACis) are currently attracting enormous attention as anticancer drugs because of their ability to inhibit cancer cell proliferation, induce cell-cycle arrest, and cause cell death12, 13. The gene discussed is HDAC9; the disease is cancer.